Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study: Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment.

NCT01722656 is registered in ClinicalTrials.gov with Southern California Desert Retina Consultants, MC as lead sponsor.

NCT NCT01722656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01722656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study: Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment.
Lead sponsor
Southern California Desert Retina Consultants, MC
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2012
Completion date
September 30, 2015
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

submacular vascularized pigment epithelial detachments